Medicure (MCUJF) Income from Continuing Operations (2009 - 2026)
Medicure (MCUJF) posted quarterly Income from Continuing Operations of 282931.81 for Q1 2026, down 34.31% year-over-year from 430694.38 in Q1 2025, and up 104.09% quarter-over-quarter from 6923468.06 in Q4 2025.
Medicure (MCUJF) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Medicure's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 282931.81 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 34.31% year-over-year to 282931.81; the TTM figure through Mar 2026 stood at 8222184.74 (down 858.76% YoY), while the FY2025 annual figure was 5079474.98, down 569.33% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 282931.81, up from 6923468.06 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3974512.36 in Q4 2022, with the low at 6923468.06 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 188346.47 (2023), against an average of 242723.77.
- Peak annual rise in Income from Continuing Operations reached 1037.96% in 2025, while the deepest fall reached 671.88% in 2025.
- Medicure's Income from Continuing Operations stood at 3974512.36 in 2022, then plunged by 130.12% to 1197292.91 in 2023, then gained by 25.08% to 896958.97 in 2024, then plunged by 671.88% to 6923468.06 in 2025, then jumped by 104.09% to 282931.81 in 2026.
- Business Quant data shows MCUJF's Income from Continuing Operations at 282931.81 in Q1 2026, 6923468.06 in Q4 2025, and 1014382.46 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | 282,931.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 282,931.81 |
| Dec 31, 2025 | -6.92 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -567,266.02 |
| Mar 31, 2025 | 430,694.38 |
| Dec 31, 2024 | -896,958.97 |
| Sep 30, 2024 | 498,476.32 |
| Jun 30, 2024 | -889,798.05 |
| Mar 31, 2024 | 37,847.77 |
| Dec 31, 2023 | -1.20 Mn |
| Sep 30, 2023 | 62,658.16 |
| Jun 30, 2023 | 188,346.47 |
| Mar 31, 2023 | 201,197.41 |
| Dec 31, 2022 | 3.97 Mn |
| Sep 30, 2022 | 837,286.90 |
| Jun 30, 2022 | 568,646.97 |
| Mar 31, 2022 | 280,263.77 |
| Dec 31, 2021 | -2.81 Mn |
| Sep 30, 2021 | 823,008.04 |
| Jun 30, 2021 | 407,577.11 |